Furen Group Pharmaceutical Co.,Ltd. Posted 133.7 Million Yuan Net Loss in First Quarter of 2023

Furen Group Pharmaceutical Co.,Ltd. (辅仁药业集团制药股份有限公司) (600781.SH) reported a net loss of 133.7 million yuan in the first quarter of 2023, narrowing 26.3% year-on-year.

Meanwhile, the company posted 462.5 million yuan in revenue, up 32.4% year-on-year.

At the end of the reporting period, it had 6.2 billion yuan in total assets and 8.4 billion yuan in total liabilities, with a liability-to-asset ratio of 135.9%.